Targets in Gene Therapy 2011
DOI: 10.5772/21081
|View full text |Cite
|
Sign up to set email alerts
|

Gene Modulation by Peptide Nucleic Acids (PNAs) Targeting microRNAs (miRs)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 90 publications
(59 reference statements)
0
7
0
1
Order By: Relevance
“…This was obtained in the absence of any transfection reagents, since the PNA was linked to a cell-penetrating peptide, R6-penetratin. In a second study, a PNA against miRNA-155 was used, demonstrating deregulation of the target mRNA Bat5 (2.7-fold increase of mRNA in PNA-treated cells), Sfp1 (2.7-fold Adapted from Marchelli et al [17].…”
Section: Biological Effects Of Treatment Of Target Cells With Anti-mimentioning
confidence: 99%
See 2 more Smart Citations
“…This was obtained in the absence of any transfection reagents, since the PNA was linked to a cell-penetrating peptide, R6-penetratin. In a second study, a PNA against miRNA-155 was used, demonstrating deregulation of the target mRNA Bat5 (2.7-fold increase of mRNA in PNA-treated cells), Sfp1 (2.7-fold Adapted from Marchelli et al [17].…”
Section: Biological Effects Of Treatment Of Target Cells With Anti-mimentioning
confidence: 99%
“…The first objective of this strategy is to obtain PNAs with both peptide properties and RNA binding ability, allowing a further improvement of the efficiency of PNA in miRNA targeting [17]. In this respect, the use of peptides as carriers represents a possible problem of the potential PNA-based drug candidates, since the peptide part might be subjected to enzymatic degradation; the incorporation of the positive-charged peptides within the PNA backbone (and not at C-or N-terminus) does not lead to enzymatic degradation, even in the presence of highly active proteases [17].…”
Section: Future Perspectivementioning
confidence: 99%
See 1 more Smart Citation
“…Since their discovery as structural DNA analogs containing an uncharged N-(2-aminoethyl) glycine-based pseudopeptide backbone and mimicking DNA by forming Watson–Crick complementary duplexes with normal DNA [ 34 , 35 ], charge-neutral peptide nucleic acids (PNAs) have demonstrated tremendous potential for antigene and antisense therapy, functional genomics, or as a probe, useful in the toolbox for diagnosis and detection [ 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 ], and constitute an excellent model substrate for devising innovative approaches directed at nucleic acids’ primary structure reading.…”
Section: Introductionmentioning
confidence: 99%
“…Though there are some of the disadvantages with unmodified PNA regarding cellular uptake, covalent coupling of PNA is required with cell penetrating peptides which improves cytosolic delivery. Artificial PNA oligomers which generally require 20-25 bases oligonucleotide probes have been used frequently in diagnosis, molecular biology procedures, antigene and antisense therapies (Marchelli et al, 2011). PNA is neither a nucleic acid nor a protein and it can withstand both nucleases and proteases; so has become a potential biomolecular tool with a superior lifetime for in vivo and in vitro applications such as, molecular diagnostics and antisense therapeutics (Janson and During, 2006).…”
Section: Introductionmentioning
confidence: 99%